SQSTM1 and amyotrophic lateral sclerosis: In addition, mutations in SQSTM1 are also known to contribute to 1%–3.5% of patients with ALS/FTD with or without familial history (Rubino et al., 2012), a similar frequency to the one we found in our sIBM cohort.